Annie Valette
Impact in
- Clinical Biochemistry top 1%
- Metabolism and Genetic Disorders
- Molecular Biology top 2%
- Mitochondrial Function and Pathology
- ATP Synthase and ATPases Research
- Cell death mechanisms and regulation
- Ubiquitin and proteasome pathways
Papers in
- Oncology 25
- Cancer-related Molecular Pathways 14
- Cell Biology 13
- Microtubule and mitosis dynamics 12
- Co-authors
- Guy LenaersAurélien OlichonPascale BelenguerNicole GasEmmanuelle GuillouLaurent BaricaultSimone VidalNadia Barboule
- Journals
- International Journal of Cancer (7 papers)Cell Cycle (5 papers)FEBS Letters (4 papers)Biochemical Pharmacology (4 papers)Experimental Cell Research (4 papers)
- Partner nations
- FranceUnited StatesMorocco
In The Last Decade
Annie Valette
59 papers receiving 3.4k citations
Hit Papers
Peers
Comparison fields: 5 of 111
- Clinical Biochemistry 398
- Molecular Biology 2.6k
- Oncology 730
- Cell Biology 364
- Cancer Research 283
Countries citing papers authored by Annie Valette
This map shows the geographic impact of Annie Valette's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Annie Valette with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Annie Valette more than expected).
Fields of papers citing papers by Annie Valette
This network shows the impact of papers produced by Annie Valette. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Annie Valette. The network helps show where Annie Valette may publish in the future.
Co-authors
The 25 scholars most cited alongside Annie Valette, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2012 | 115 | |
| 2 | 2009 | 38 | |
| 3 | 2009 | 15 | |
| 4 | 2008 | 42 | |
| 5 | A novel synthetic CDC25 phosphatase inhibitor inhibits human cancer growth in vitro and in vivo | 2007 | 1 |
| 6 | 2002 | 38 | |
| 7 | 2002 | 344 | |
| 8 | 2000 | 9 | |
| 9 | 2000 | 18 | |
| 10 | 1999 | 70 | |
| 11 | 1999 | 45 | |
| 12 | 1998 | 35 | |
| 13 | 1997 | 29 | |
| 14 | 1995 | 20 | |
| 15 | 1995 | 30 | |
| 16 | 1995 | 37 | |
| 17 | 1992 | 20 | |
| 18 | 1990 | 6 | |
| 19 | 1990 | 19 | |
| 20 | 1983 | 29 |
About Annie Valette
Annie Valette is a scholar working on Oncology, Cell Biology, Molecular Biology, Toxicology and Cancer Research, having authored 59 papers that have together received 3.5k indexed citations. Recurring topics across this work include Cancer-related Molecular Pathways (14 papers), Microtubule and mitosis dynamics (12 papers), TGF-β signaling in diseases (9 papers), Cell death mechanisms and regulation (8 papers), Estrogen and related hormone effects (7 papers), Mitochondrial Function and Pathology (6 papers), Receptor Mechanisms and Signaling (6 papers) and Retinoids in leukemia and cellular processes (5 papers). The work is most often cited by research in Clinical Biochemistry (398 citations), Molecular Biology (2.6k citations), Oncology (730 citations), Cell Biology (364 citations) and Cancer Research (283 citations). Annie Valette has collaborated with scholars based in France, United States and Morocco. Frequent co-authors include Guy Lenaers, Aurélien Olichon, Pascale Belenguer, Nicole Gas, Emmanuelle Guillou, Laurent Baricault, Simone Vidal, Nadia Barboule, Laetitia Brichese and Bernard Ducommun. Their work appears in journals such as International Journal of Cancer, Cell Cycle, FEBS Letters, Biochemical Pharmacology and Experimental Cell Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.